Recursion

recursionpharma.bsky.social

22 May 2025 18:58

A new perspective paper from Recursion and our AI research engine @valenceai.bsky.social lays out our vision for a virtual cell as a system that can reliably drive the discovery of new drugs via an iterative loop of: predict, explain, discover. arxiv.org/abs/2505.14613 #TechBio 🧪

Recursion

recursionpharma.bsky.social

20 May 2025 17:43

At the J.P. Morgan 53rd Annual Global Technology, Media, & Communications Conference, Recursion CFO Ben Taylor & Lina Nilsson, SVP Head of Platform, discussed tangible progress in AI drug discovery, the evolution of our platform & delivering for partners. jpmorgan.metameetings.net/events/tmc25...

Recursion

recursionpharma.bsky.social

13 January 2025 20:52

Advancing our vision for a virtual cell: In a presentation at #JPM2025, CEO Chris Gibson shared his vision for #TechBio, in which biol & chem datasets & highly predictive ML models, including advanced protein folding, will allow us to build a true virtual cell. ir.recursion.com/static-files...

Recursion

recursionpharma.bsky.social

20 December 2024 19:32

Leveraging AI & ML to improve healthcare outcomes. Najat Khan, Chief R&D & Chief Commercial Officer & Dave Hallett, CSO, spoke to Nasdaq MarketSite about how we're using AI & ML to accelerate improvements in time, cost & success rates of drug discovery & development. www.nasdaq.com/videos/recur...

Kristina Ulicna

kristinaulicna.bsky.social

20 December 2024 18:25

🚀 Meet Kristina Ulicna (@kristinaulicna.bsky.social at @valenceai.bsky.social), a Research Scientist in #AI driven single-cell representations. From @uclofficial.bsky.social to Turing Inst to #WiML volunteer, Kristina brings expertise in imaging & interpretable AI to #LMRL. Ready for #ICLR2025! 🌟